Lee Hambright
Stock Analyst at Bernstein
(3.42)
# 978
Out of 5,042 analysts
27
Total ratings
78.95%
Success rate
11.18%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Market Perform | $172 → $193 | $190.40 | +1.37% | 5 | Oct 6, 2025 | |
| MDT Medtronic | Maintains: Outperform | $97 → $98 | $93.67 | +4.62% | 3 | Aug 20, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $138 → $144 | $126.85 | +13.52% | 5 | Apr 17, 2025 | |
| PODD Insulet | Initiates: Outperform | $300 | $320.91 | -6.52% | 1 | Nov 6, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Outperform | $42 | $14.95 | +180.94% | 1 | Nov 6, 2024 | |
| DXCM DexCom | Maintains: Outperform | $82 → $86 | $70.33 | +22.28% | 2 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $92 → $100 | $101.11 | -1.10% | 1 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $350 → $365 | $546.51 | -33.21% | 2 | May 31, 2023 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $136 → $152 | $103.03 | +47.53% | 1 | May 3, 2023 | |
| SYK Stryker | Upgrades: Outperform | $288 → $295 | $381.79 | -22.73% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $76.10 | +77.40% | 3 | Mar 16, 2022 |
Johnson & Johnson
Oct 6, 2025
Maintains: Market Perform
Price Target: $172 → $193
Current: $190.40
Upside: +1.37%
Medtronic
Aug 20, 2025
Maintains: Outperform
Price Target: $97 → $98
Current: $93.67
Upside: +4.62%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $138 → $144
Current: $126.85
Upside: +13.52%
Insulet
Nov 6, 2024
Initiates: Outperform
Price Target: $300
Current: $320.91
Upside: -6.52%
Tandem Diabetes Care
Nov 6, 2024
Initiates: Outperform
Price Target: $42
Current: $14.95
Upside: +180.94%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $82 → $86
Current: $70.33
Upside: +22.28%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $101.11
Upside: -1.10%
Intuitive Surgical
May 31, 2023
Maintains: Outperform
Price Target: $350 → $365
Current: $546.51
Upside: -33.21%
Zimmer Biomet Holdings
May 3, 2023
Maintains: Market Perform
Price Target: $136 → $152
Current: $103.03
Upside: +47.53%
Stryker
Mar 16, 2022
Upgrades: Outperform
Price Target: $288 → $295
Current: $381.79
Upside: -22.73%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $76.10
Upside: +77.40%